SCHEMBL30059386

SCHEMBL30059386

CCCCOC(=O)NC[C@H]1C[C@H](O)C1

nearest known ligand 0.49

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 14/20 0.49
▸ EPHX1 P07099 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16145641 0.85 ACHE (0.53) ACHEEPHX1
SCHEMBL16145948 0.83 ACHE (0.47) ACHEEPHX1
SCHEMBL13387497 0.81 ACHE (0.49) ACHEEPHX1
SCHEMBL14469954 0.79 ACHE (0.47) ACHE
SCHEMBL8258529 0.79 ACHE (0.47) ACHE
SCHEMBL10794458 0.79 ACHE (0.59) ACHEEPHX1
SCHEMBL29696546 0.78 ACHE (0.46) ACHE
SCHEMBL7051358 0.78 GNAI3 (0.49) ACHE
SCHEMBL30849236 0.78 ACHE (0.46) ACHE
SCHEMBL8389807 0.78 ACHE (0.50) ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4077283-A1 PROGRANULIN MODULATORS AND METHODS OF USING THE SAME Arkuda Therapeutics (US) 2022-10-26 — — EP disclosed
Send feedback